Hemin-coupled iron(III)-hydroxide nanoparticles show increased uptake in Caco-2 cells

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 12, 2011, Pages 1522-1530

  Jahn, Markus Richard ^a   Shukoor, Ibrahim ^b   Tremel, Wolfgang ^b   Wolfrum, Uwe ^c   Kolb, Ute ^a   Nawroth, Thomas ^a   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Institute of Inorganic and Analytical Chemistry   (Germany)

^c Institute of Zoology   (Germany)

Author keywords

absorption; Caco 2 cells; iron deficiency; iron(III) hydroxide nanoparticles; oral delivery

Indexed keywords

DRUG CARRIER; FERRIC HYDROXIDE; HEMIN; NANOPARTICLE;

ARTICLE; CELL STRAIN CACO 2; COLORIMETRY; CONTROLLED STUDY; COVALENT BOND; DRUG ABSORPTION; DRUG FORMULATION; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; IRON TRANSPORT; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

CACO-2 CELLS; COLORIMETRY; COLORING AGENTS; CULTURE MEDIA; FERRIC COMPOUNDS; FERROZINE; HEMIN; HUMANS; IRON CHELATING AGENTS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; SCATTERING, RADIATION; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TETRAZOLIUM SALTS; THIAZOLES;

EID: 80855156687     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01356.x     Document Type: Article

References (51)

1. Heinrich HC,. [Bioavailability and therapeutic efficacy of oral iron(II)- and iron(III) preparations]. Dtsch Apoth Ztg 1986; 126: 681-690 [in German]. (Pubitemid 16102271)
2. Gillooly M, et al,. The effects of organic acids, phytates and polyphenols on the absorption of iron from vegetables. Br J Nutr 2007; 49: 331-342.
3. Hallberg L,. Bioavailability of dietary iron in man. Annu Rev Nutr 1981; 1: 123-147.
4. Ammon HPT,. [Drug Side Effects and Drug Interactions], 1st edn. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2001 [in German].
5. Geisser P,. Iron therapy and oxidative stress. Met Based Drugs 1997; 4: 137-152. (Pubitemid 27351189)
6. Halliwell B, Gutteridge JM,. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85. (Pubitemid 20279941)
7. Jahn MR, et al,. CE characterization of potential toxic labile iron in colloidal parenteral iron formulations using off-capillary and on-capillary complexation with EDTA. Electrophoresis 2007; 28: 2424-2429. (Pubitemid 47162937)
8. Geisser P,. Safety and efficacy of iron (III)-hydroxide polymaltose complex: a review of over 25 years experience. Arzneimittelforschung 2007; 57: 439-452. (Pubitemid 47055995)
9. Geisser P, Muller A,. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Arzneimittelforschung 1987; 37: 100-104. (Pubitemid 17219718)
10. 59Fe. Arzneimittelforschung 2007; 57: 401-416. (Pubitemid 47055991)
11. Burckhardt-Herold S, et al,. Interactions between iron (III)-hydroxide polymaltose complex and commonly used drugs: simulations and in vitro studies. Arzneimittelforschung 2007; 57: 360-369. (Pubitemid 47055986)
12. Potgieter MA, et al,. Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia. Arzneimittelforschung 2007; 57: 385-391. (Pubitemid 47055989)
13. Potgieter MA, et al,. Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia: a single-centre randomized controlled isotope study. Arzneimittelforschung 2007; 57: 392-400. (Pubitemid 47055990)
14. Toblli JE, Brignoli R,. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia: review and meta-analysis. Arzneimittelforschung 2007; 57: 431-438. (Pubitemid 47055994)
15. Jung T, et al,. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 2000; 50: 147-160. (Pubitemid 30326694)
16. Schipper NG, et al,. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997; 14: 923-929. (Pubitemid 27326989)
17. Kriwet B, Kissel T,. Poly (acrylic acid) microparticles widen the intercellular spaces of caco-2 cell monolayers: an examination by confocal laser scanning microscopy. Eur J Pharm Biopharm 1996; 42: 233-240. (Pubitemid 26294953)
18. Sun C, et al,. Magnetic nanoparticles in mr imaging and drug delivery. Adv Drug Deliv Rev 2008; 60: 1252-1265.
19. Hussain N, et al,. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res 1997; 14: 613-618. (Pubitemid 27220279)
20. Russell-Jones GJ, et al,. Vitamin B12-mediated transport of nanoparticles across caco-2 cells. Int J Pharm 1999; 179: 247-255. (Pubitemid 29131434)
21. Chalasani KB, et al,. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Release 2007; 117: 421-429. (Pubitemid 46237606)
22. Jani P, et al,. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 1990; 42: 821-826.
23. Behrens I, et al,. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res 2002; 19: 1185-1193. (Pubitemid 34985003)
24. Pinto-Alphandary H, et al,. Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm Res 2003; 20: 1071-1084. (Pubitemid 36774279)
25. Seligman PA, et al,. Clinical studies of hip: an oral heme-iron product. Nutr Res 2000; 20: 1279-1286.
26. Shayeghi M, et al,. Identification of an intestinal heme transporter. Cell 2005; 122: 789-801. (Pubitemid 41242642)
27. Qiu A, et al,. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006; 127: 917-928. (Pubitemid 44792250)
28. West AR, Oates PS,. Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol 2008; 14: 4101-4110.
29. Tandy S, et al,. NRAMP2 expression is associated with ph-dependent iron uptake across the apical membrane of human intestinal caco-2 cells. J Biol Chem 2000; 275: 1023-1029. (Pubitemid 30051149)
30. Latunde-Dada GO, et al,. Haem carrier protein 1 (HCP1): expression and functional studies in cultured cells. FEBS Lett 2006; 580: 6865-6870. (Pubitemid 44914141)
31. Desai MP, et al,. The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharm Res 1997; 14: 1568-1573. (Pubitemid 28009208)
32. Alvarez-Hernandez X, et al,. Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers. Biochim Biophys Acta 1991; 1070: 205-208.
33. Choi H, et al,. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 2004; 11: 996-1004. (Pubitemid 39220809)
34. Fish WW,. Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. Methods Enzymol 1988; 158: 357-364.
35. National Cancer Institute. NCL method GTA-1, version 1.0, LLC-PK1 kidney cytotoxicity assay. 2005.
36. Alben JO,. Infrared spectroscopy of porphyrins. In:, Dolphin D, ed. The Porphyrins, Volume III, Physical Chemistry, Part A. New York: Academic Press, 1978: 323-345.
37. Teva Germany. Cosmofer® summary of product characteristics. 2007.
38. Watson Pharma. Infed® iron dextran injection USP. 2006.
39. Kumar S, Bandyopadhyoy U,. Free heme toxicity and its detoxification system in humans. Toxicol Lett 2005; 157: 175-188. (Pubitemid 40726102)
40. Smith A, Morgan WT,. Hemopexin-mediated heme uptake by liver. Characterization of the interaction of heme-hemopexin with isolated rabbit liver plasma membranes. J Biol Chem 1984; 259: 12049-12053. (Pubitemid 14022137)
41. Gräsbeck R, et al,. An intestinal receptor for heme. Scand J Haematol 1979; 23: 5.
42. Galbraith RA,. Heme binding to HEPG2 human hepatoma cells. J Hepatol 1990; 10: 305-310. (Pubitemid 20162737)
43. Galbraith RA, et al,. Heme binding to murine erythroleukemia cells. Evidence for a heme receptor. J Biol Chem 1985; 260: 12198-12202. (Pubitemid 16228388)
44. Gräsbeck R, et al,. Spectral and other studies on the intestinal haem receptor of the pig. Biochim Biophys Acta 1982; 700: 137-142.
45. Parmley RT, et al,. Ultrastructural cytochemistry and radioautography of hemoglobin-iron absorption. Exp Mol Pathol 1981; 34: 131-144. (Pubitemid 11100956)
46. Yin Win K, Feng S-S,. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005; 26: 2713-2722. (Pubitemid 39600724)
47. Roberts SK, et al,. Modulation of uptake of heme by rat small intestinal mucosa in iron deficiency. Am J Physiol 1993; 265: G712-G718.
48. Worthington MT, et al,. Characterization of a human plasma membrane heme transporter in intestinal and hepatocyte cell lines. Am J Physiol Gastrointest Liver Physiol 2001; 280: 1172-1177.
49. Uc A, et al,. Heme transport exhibits polarity in caco-2 cells: evidence for an active and membrane protein-mediated process. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1150-G1157. (Pubitemid 39551844)
50. Conroy Sun RSMZ,. Folic acid-peg conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 2006; 78A: 550-557.
51. Florence AT, et al,. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target 1995; 3: 65-70.